Article Text

Download PDFPDF

AB0723 Technical aids agreed among specialists for the management of comorbidity in patients with axial spondyloarthritis: the gecoax project
  1. C González1,
  2. R Curbelo2,
  3. JC Torre-Alonso3,
  4. E Collantes4,
  5. S Castañeda5,
  6. MV Hernández6,
  7. A Urruticoechea-Arana7,
  8. JC Nieto1,
  9. J García8,
  10. MΆ Abad9,
  11. J Ramírez6,
  12. C Suárez10,
  13. R Dalmau11,
  14. MD Martín-Arranz12,
  15. L Leόn13,
  16. JC Hermosa14,
  17. JC Obaya15,
  18. T Otόn2,
  19. L Carmona2
  1. 1Rheumatology, HU Gregorio Marañόn
  2. 2InMusc, Madrid
  3. 3Rheumatology, HU Monte Naranco, Oviedo
  4. 4Rheumatology, HU Reina Sofía, Cόrdoba
  5. 5Rheumatology, HU la Princesa, IIS-IP, Madrid
  6. 6Rheumatology, HU Clinic i Provincial, Barcelona
  7. 7Rheumatology, H Can Misses, Ibiza
  8. 8Rheumatology, HU 12 de Octubre, Madrid
  9. 9Rheumatology, H de Plasencia, Plasencia
  10. 10Internal Medicine, HU la Princesa, IIS-IP
  11. 11Cardiology
  12. 12Gastroenterology, HU la Paz
  13. 13Psychology, UCJC, Madrid
  14. 14Centro de Salud Ciudades, Getafe
  15. 15Centro de Salud Alcobendas, Alcobendas, Spain


Background The management of comorbidity in patients with axial spondyloarthritis (Ax-SpA) needs improvement; the implementation of clinical practice guidelines is still deficient and heterogeneous.

Objectives To prioritise comorbidities in Ax-SpA and to elaborate practical aids for their identification and follow-up.

Methods A multidisciplinary panel [10 rheumatologists (6 experts in Ax-SpA), 2 family doctors, 1 internist, 1 cardiologist, 1 gastroenterologist, 1 psychologist and 3 methodologists] prioritised, in a discussion group, a list of comorbidities based on frequency and impact. Each comorbidity was discussed largely and systematic reviews were performed to support or discard items. In a second meeting, items to be included were presented, discussed, and those with lower priority disregarded.

Results The panel produced a checklist for health professionals and another for patients. Each item is supported by arguments and references. Table 1 shows, schematically, the items included in the checklists.

Table 1.

Items included in the checklist

Conclusions These checklists are intended to facilitate the systematic evaluation of co-morbidity associated with Ax-SpA, thus allowing an earlier detection and better control and management of these patients by the rheumatologist.

Acknowledgements This project was funded by Merck Sharp & Dohme Spain. Merck Sharp & Dohme had no influence on either the development of the project or the final content of the abstract.

Disclosure of Interest None declared

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.